Search Results

173 Results for "biophytis".

Sort By

Press Releases

Biophytis Revolutionizes Sarcopenia

March 17, 2025
·
3 min read
Press Releases

Biophytis Unveils Its Outlook Strategies for 2025

February 11, 2025
·
4 min read
Press Releases

Biophytis Announces Its Participation to the BIOMED FORUM Investor Conference

January 27, 2025
·
2 min read
Press Releases

Biophytis Announces its Participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR)

February 25, 2025
·
3 min read
Press Releases

Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China

January 21, 2025
·
5 min read
Press Releases

Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101

January 14, 2025
·
3 min read
Genetown

Biophytis is Deploying its Partnership Strategy in Obesity

Biophytis SA announces the implementation of a dedicated strategy for partner search in obesity.

April 29, 2024
·
4 min read
Drug Development

Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity

Biophytis SA announces the design of its phase 2 OBA clinical study in obesity with BIO101.

May 14, 2024
·
4 min read
Genetown

Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by its Service Provider Seqens

Biophytis SA, a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, announces the successful transfer of BIO101 production to industrial scale by Seqens.

June 12, 2024
·
3 min read
Genetown

Biophytis grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million

Biophytis SA announces the signature of an exclusive license agreement with Blanver, one of the leading and most trusted pharmaceutical company in Brazil, for BIO101 in Latin American including, but not limited to Brazil, Mexico, Argentina and Colombia.

June 20, 2024
·
5 min read